
Paris, April 1st, 2011
AREVA Foundation and Institut Pasteur sign a new partnership agreement for Aids research
• the team led by Professor Olivier Schwartz, who directs the Virus and Immunity Research Unit
• the team of Dr. Michaela Müller of the Retroviral Infection Regulation Unit directed by Professor Barré-Sinoussi, Nobel Prize in Medicine.
For both teams, the objective is to understand how HIV causes chronic inflammation of the immune system. The researchers also want to determine how the virus alters the cellular environment to promote its propagation in the organism.
This basic research is accompanied by applied research in areas such as the search for new antiviral drugs and pre-clinical analysis of candidate vaccines.
Institut Pasteur programs supported by AREVA
Ever since it was created, AREVA Foundation has supported the Institut Pasteur’s projects.
These include the Institut Pasteur of Shanghai program concerning the impact of climate change on viral disease. From 2005 to 2010, forums and discussions on the reemergence of infectious disease, disease vectors and the fight against Aids have helped lay the foundations of strategies for combatting emerging diseases.
At the same time, AREVA Foundation is supporting the work of Dr. Florence Buseyne of the Viral Immunopathology Unit at the Institut Pasteur in Paris. This research project centers on the detailed immunology of patients suffering from HIV since childhood. The objective is to improve knowledge of the disease and strengthen therapeutic care for subjects infected at birth.
AREVA Foundation
In 2007, AREVA established a corporate foundation that supports aid programs in two key fields:
- health, with emphasis on the fight against Aids and support to patients living with the virus
- knowledge sharing, with a commitment to erasing illiteracy and providing access to education.
In 2010, AREVA Foundation helped deploy 35 projects in some 15 countries, including 17 projects led by the group’s employees.
About AREVA
Every day, AREVA’s 48,000 employees cultivate the synergies between these two major carbon-free offers, helping to supply safer, cleaner and more economical energy to the greatest number of people.
About the Institut Pasteur
Along with research on living science, a large part of its work is devoted to the study of infectious disease, genetic disease, neuro-degenerative disease and some cancers. The Institut Pasteur is the hub of an international network of 32 institutes on every continent. Ten of its researchers have received the Nobel Prize in Medicine since its establishment.
Press contacts
tel : +33 1 34 96 12 15
fax : +33 1 34 96 16 54
press@areva.com
Institut Pasteur
Nadine Peyrolo
+ 33 (0)1 45 68 81 47
presse@pasteur.fr